10887 related articles for article (PubMed ID: 10465582)
1. Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10.
Ekmekcioglu S; Okcu MF; Colome-Grimmer MI; Owen-Schaub L; Buzaid AC; Grimm EA
Melanoma Res; 1999 Jun; 9(3):261-72. PubMed ID: 10465582
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
Arnold R; Seifert M; Asadullah K; Volk HD
J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
[TBL] [Abstract][Full Text] [Related]
3. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
[TBL] [Abstract][Full Text] [Related]
4. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
Ragnarsson GB; Mikaelsdottir EK; Vidarsson H; Jónasson JG; Olafsdóttir K; Kristjánsdóttir K; Kjartansson J; Ogmundsdóttir HM; Rafnar T
Br J Cancer; 2000 Dec; 83(12):1715-21. PubMed ID: 11104571
[TBL] [Abstract][Full Text] [Related]
5. Frequent downregulation of Fas (CD95) expression and function in melanoma.
Bullani RR; Wehrli P; Viard-Leveugle I; Rimoldi D; Cerottini JC; Saurat JH; Tschopp J; French LE
Melanoma Res; 2002 Jun; 12(3):263-70. PubMed ID: 12140383
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha and interferon-gamma induce expression of functional Fas ligand on HT29 and MCF7 adenocarcinoma cells.
Naujokat C; Sezer O; Possinger K
Biochem Biophys Res Commun; 1999 Nov; 264(3):813-9. PubMed ID: 10544014
[TBL] [Abstract][Full Text] [Related]
7. Induction of Fas-mediated apoptosis in a human renal epithelial cell line by interferon-gamma: involvement of Fas-mediated apoptosis in acute renal rejection.
Akasaka Y; Ishikawa Y; Kato S; Ishii T; Masuda T; Fujita K; Yamada T; Kawamura S
Mod Pathol; 1998 Nov; 11(11):1107-14. PubMed ID: 9831209
[TBL] [Abstract][Full Text] [Related]
8. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
Shukuwa T; Katayama I; Koji T
Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.
Aschkenazi S; Straszewski S; Verwer KM; Foellmer H; Rutherford T; Mor G
Biol Reprod; 2002 Jun; 66(6):1853-61. PubMed ID: 12021072
[TBL] [Abstract][Full Text] [Related]
10. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
[TBL] [Abstract][Full Text] [Related]
11. Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.
Ivanov VN; Hei TK
Exp Cell Res; 2006 May; 312(8):1401-17. PubMed ID: 16487513
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
13. Fas ligand reduces viability in primary melanoma short-term cell cultures more than in metastatic melanoma short-term cell cultures.
Hofbauer GF; Hatta N; Daigle I; Hemmi S; Spanaus Schlapbach K; Willers J; Burg G; Simon HU; Dummer R
Dermatology; 2005; 211(4):318-24. PubMed ID: 16286739
[TBL] [Abstract][Full Text] [Related]
14. Fas and Fas ligand: expression and soluble circulating levels in cutaneous malignant melanoma.
Redondo P; Solano T; VAzquez B; Bauza A; Idoate M
Br J Dermatol; 2002 Jul; 147(1):80-6. PubMed ID: 12100188
[TBL] [Abstract][Full Text] [Related]
15. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
16. Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.
De Paola F; Ridolfi R; Riccobon A; Flamini E; Barzanti F; Granato AM; Mordenti GL; Medri L; Vitali P; Amadori D
Br J Cancer; 2003 Jan; 88(2):320-6. PubMed ID: 12610520
[TBL] [Abstract][Full Text] [Related]
17. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.
Andreola G; Rivoltini L; Castelli C; Huber V; Perego P; Deho P; Squarcina P; Accornero P; Lozupone F; Lugini L; Stringaro A; Molinari A; Arancia G; Gentile M; Parmiani G; Fais S
J Exp Med; 2002 May; 195(10):1303-16. PubMed ID: 12021310
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes.
Ferrarini M; Imro MA; Sciorati C; Heltai S; Protti MP; Pellicciari C; Rovere P; Manfredi AA; Rugarli C
Int J Cancer; 1999 May; 81(4):573-9. PubMed ID: 10225447
[TBL] [Abstract][Full Text] [Related]
19. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
20. Fas and FasL expression on cells of two transplantable melanoma lines according to their different biological properties.
Zielińska K; Kozłowska K; Cichorek M; Wachulska M
Folia Histochem Cytobiol; 2008; 46(3):337-43. PubMed ID: 19056538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]